biostudies-literatureUnknown24(5)Attard GCancer Research UKMedical Research CouncilNational Institute for Health Research (NIHR)Prostate Cancer ResearchThe Lancet. Oncology443-456https://www.ebi.ac.uk/biostudies/studies/S-EPMC7616864biostudies-literatureAbiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol.PMC7616864MRC_MC_UU_12023/25CRUK_A22744CRUK_A124596957MC_UU_00004/01MC_UU_12023/25John HBrawley CTanguay JSheehan DSmith-Howell MFackrell DBerthold DAlzouebi MNarahari KVilarino-Varela MRobson PParmar MKBDouglas FBloomfield DKagzi MAhmed ITaylor HHughes RSabharwal APereira Mestre RMasters BSreenivasan TMason MDParkar NConroy RBahl AAttard GBorner MJames NDChan APaisey SShaffer RWylie JIbrahim AStrebel RCook AMurphy CHoskin PBrock SDurr DJain YDealey RHofmann USundar SPedley INikapota APorfiri EThomas CSydes MRLee LParikh OJones ECross WPugh CFalconer AJones CSTAMPEDE investigatorsMelcher LDearnaley DPPerna CSayers IBirtle ATipples KBrown MDGillessen SGlen HCarser JKhan MMSivoglo VTran ARudman SMullessey VCrabb SMatheson DAzzabi AGray EAfshar MHingorani MMcPhail NLogue JParker CCBrown LCWoodward CSaxby HGilson CGibbs SSrihari NSidek NBeyer JJones RJSangar VMullassery VHamid AHoyle AShaheen APorter TSimms MBrulinski PProtheroe AGupta NRoggero EAmos CLPhan MDGilbert DRentsch CEngeler DHyde KClarke NWMcGovern UGraham JVengalil SRush HBhalla NRussell JMAbdel-Aty HHilman SVivekanandan SKhan YChowdhury SBeresford MDas PAlameddine MBrierly RWagstaff JRogers PZarkar ABoussios SMurphy LLeaning DCapaldi LPopescu RMillman RWalker GGrant WPeedell CSachdeva AO'Sullivan JMMcLaren DGale JMontazeri AHLangley REWorlding JWhelan PJoseph JPezaro CRobinson ACathomas RMazhar DKhoo VNeedleman SFord DKhan OKeng-Koh PMalik ZKumar ADiaz-Montana CBrown SMuthukumar DManetta CTarver KfalseAbiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol.2023-01-01T00:00:00Z2023 May2026-06-01T13:39:11.417Z2025-04-21T21:45:48.291ZS-EPMC76168643714237110.1016/S1470-2045(23)00148-1